ARKG Holdings of RXRX
Recursion Pharmaceuticals
Recursion Pharmaceuticals operates as a biotechnology company that leverages machine learning and automation to discover new drugs and advance them through the drug development pipeline more efficiently. The company generates revenue primarily through partnerships and collaborations with other pharmaceutical firms, leveraging its proprietary technology and expertise to aid in drug discovery and development efforts.
Trades of RXRX in ARKG
The ten most recent trades of Recursion Pharmaceuticals in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Jan 03, 2025 | Buy | $336,653 | 0.39% | 0.03% |
| Nov 25, 2024 | Buy | $595,896 | 0.84% | 0.05% |
| Nov 20, 2024 | Buy | $349,547 | 0.50% | 0.03% |
| Nov 06, 2024 | Buy | $127,130 | 0.16% | 0.01% |
| Oct 08, 2024 | Buy | $147,632 | 0.20% | 0.01% |
| Oct 07, 2024 | Buy | $1,879,173 | 2.76% | 0.15% |
| Sep 06, 2024 | Buy | $508,806 | 0.75% | 0.04% |
| Sep 04, 2024 | Buy | $1,904,164 | 2.93% | 0.15% |
| Sep 03, 2024 | Buy | $1,093,952 | 1.63% | 0.08% |
| Aug 23, 2024 | Buy | $88,469 | 0.11% | 0.01% |